Business
Deferred Bonus Plan and LTIP Option Grants
Deferred Bonus Plan and LTIP Option Grants.
About this update from Oxford Biomedica Plc
[{"type":"text","content":"\n \nRNS Number : 8313W Oxford Biomedica PLC 23 April 2019 \n\n \n \nDeferred Bonus Plan and Long Term Incentive Plan Option Grants\n \nLondon, UK - 23 April 2019: Oxford Biomedica plc (\"Oxford Biomedica\" or the \"Company\") (LSE:OXB), a leading gene and cell therapy Group announces that on 18 April 2019 nil-cost share options over shares of 50 pence each in the Company were granted to the Senior Executive Team under the Oxford Biomedica 2015 Deferred Bonus Plan (\"DBP\") and the Oxford Biomedica 2015 Long Term Incentive Plan (\"LTIP\").\n \nThe grant of the share options comprises two types of award, which are: (i) the grant of the 2019 LTIP awards and; (ii) the grant of the 2019 DBP awards. \n \n\n\n\nName of individual\n\n\nTitle\n\n\nNumber of shares subject to the 2019 DBP award\n\n\nNumber of shares subject to the 2019 LTIP award\n\n\nTotal shares over which options are held (note 1)\n\n\nPercentage of issued share capital under option\n\n\n\n\nJohn Dawson\n\n\nChief Executive Officer\n\n\n31,179\n\n\n72,736\n\n\n697,680\n\n\n1.0%\n\n\n\n\nStuart Paynter\n\n\nChief Financial Officer\n\n\n17,820\n\n\n32,358\n\n\n143,294\n\n\n0.2%\n\n\n\n\nJames Miskin\n\n\nChief Technical Officer\n\n\n7,634\n\n\n28,384\n\n\n199,290\n\n\n0.3%\n\n\n\n\nKyriacos Mitrophanous\n\n\nChief Scientific Officer\n\n\n7,634\n\n\n28,384\n\n\n200,350\n\n\n0.3%\n\n\n\n\nLisa Giles\n\n\nChief Project & Performance Officer\n\n\n4,846\n\n\n22,658\n\n\n44,653\n\n\n0.07%\n\n\n\n\nNick Page\n\n\nChief Operations Officer\n\n\n6,178\n\n\n29,967\n\n\n58,827\n\n\n0.09%\n\n\n\n\nHelen Stephenson-Ellis\n\n\nChief People Officer\n\n\n3,797\n\n\n19,869\n\n\n37,607\n\n\n0.06%\n\n\n\n\nJason Slingsby\n\n\nChief Business Officer\n\n\n7,232\n\n\n27,675\n\n\n103,836\n\n\n0.2%\n\n\n\nNotes:\n1. Includes the 2014 DBP awards to be met by market purchased shares held by the Oxford Biomedica Employee Trust\n \n \nUnder the terms of the 2015 DBP, the DBP awards will become exercisable as to one third of the shares subject to each award on each of the first three anniversaries of the grant date.\n \nThe 2019 LTIP awards are subject to a three year performance period and become exercisable from the third anniversary of the grant date, subject to the satisfaction of a perfo...